Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030

Similar documents
Copenhagen, Denmark, September August Malaria

54% WHO s emergency response to artemisinin resistance SHARP DECLINE IN MALARIA CASES AND DEATHS SEEN ACROSS THE GMS BULLETIN #5 SEPTEMBER 2016

BMGF MALARIA STRATEGY TO 2020

Media centre Malaria. Key facts. Symptoms

Draft Concept Note. Launching of Sahel Malaria Elimination Initiative

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Evidence Review Group on MDA, MSAT and FSAT Malaria Policy Advisory Committee Geneva, Switzerland September 2015

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

Antimalarial drug resistance

The Challenge of Malaria

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

Malaria Situation and Plan for Elimination in China

Ethiopia Malaria Financial Landscape

Revised Strategy for Malaria Control in the South-East Asia Region

WHO Global Task Force on TB Impact Measurement An overview

Regional Action Plan

From a one-size-fits-all to a tailored approach for malaria control

Malaria Situation and Control in China

128th Session 25 November 2010 Provisional agenda item Malaria. Prevention and control: sustaining the gains and reducing transmission

Ending Malaria in Nigeria: The WHO Agenda

Global Report on Antimalarial Drug. and the Global Plan for Artemisinin Resistance Containment (GPARC)

REGIONAL ACTION PLAN FOR MALARIA CONTROL AND ELIMINATION IN THE WESTERN PACIFIC ( )

Minutes of the Drug Resistance and Containment Technical Expert Group

GREATER MEKONG SUB-REGION ELIMINATION OF MALARIA (GEMS) PRIVATE SECTOR MALARIA SURVEILLANCE

Summary World Malaria Report 2010

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Progress, challenges and the way forward in ASEAN Member States

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

Malaria. Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania

Key Messages for World Malaria Day 2009

South East Asia and China FMD Campaign

Supporting Accelerate to Zero: The BMGF Malaria Vector Control

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014

REVIEW THE CHALLENGES OF MALARIA ELIMINATION IN YUNNAN PROVINCE, PEOPLE S REPUBLIC OF CHINA

SECTOR ASSESMENT (SUMMARY): HEALTH

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

Monitoring of the achievement of the health-related Millennium Development Goals

WHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control

Regional Malaria CSO Platform, GMS: Review. October 2017

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

SEACFMD ACTIVITIES FOCUS ON

TB Disease Prevalence Survey - Progress Report

Malaria Elimination: an Operational Manual

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

ASEAN Activities on Increasing Access to ARV and HIV Related Supplies

Partnership, Cooperation and Action in the Greater Mekong Sub-region. The Memorandum of Understanding (MOU) on Drug Control

FAO s Animal Health Initiatives in Asia and the Pacific. 9th Regional Steering Committee Meeting of GF TADs for Asia and Pacific

Okinawa, Toyako, and Beyond: Progress on Health and Development

World Health Organization. A Sustainable Health Sector

Global Strategy for Women s, Children s and Adolescents Health

Malaria: draft global technical strategy: post 2015

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

3. CONCLUSIONS AND RECOMMENDATIONS

Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group -

Resolution adopted by the General Assembly on 11 September [without reference to a Main Committee (A/69/L.91 and Add.1)]

Antigua and Barbuda, Lebanon and Swaziland:* draft resolution

Policy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Malaria Elimination in Mesoamerica and the Hispaniola Island EMMIE Initiative. APMEN VII Hoi An, Vietnam March 2015

A framework for malaria elimination. Dr Pedro Alonso, GMP Director

Strengthening regional health security: Emerging diseases and disaster preparedness and response

CONSENSUS STATEMENT OF THE NATIONAL FOOD AND NUTRITION SUMMIT 2018, LUSAKA, ZAMBIA

Finding the missing TB cases

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

HIV Resource Allocations using AEM

The Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

WHO Global Malaria Programme. February 2009

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES

FMD Control in South East Asia: science based approach to development of roadmaps and PVS Tools to support capacity building.

Polio post-certification strategy

Health Task Force Workplan

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Key points and Q&A. A framework for malaria elimination (2017) Global Malaria Programme. Rationale for updated guidance.

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Botswana Private Sector Health Assessment Scope of Work

Towards a Sustainable Global Infrastructure for Medical Countermeasures

WHO Strategy and Goals for Viral Hepatitis Elimination

Cross-cutting HSS (Health Systems Strengthening): Experience from WPRO

Commonwealth Secretariat

ART for prevention the task ahead

Driving access to medicine

Global Health Policy: Vaccines

Building and Sustaining Political Commitment for Nutrition Action Lao PDR

TB Disease Prevalence Survey - Overview and Introduction of the TF

Countdown to 2015: tracking progress, fostering accountability

Progress on the Containment of Artemisinin Tolerant Malaria Parasites in South-East Asia (ARCE) Initiative

Preparing for the Next Global Threat A Call for Targeted, Decisive Action Now to Prevent The Next Pandemic

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

Introduction to PAHWP-EAC-LSHTM Workshop on Assessment of Clinical Performance of in-vitro Diagnostics

Poliomyelitis eradication in the WHO European Region

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Fifth report of Committee A

Malaria Symposia Myanmar Medical Association. Dr Aung Thi National Malaria Control Program 04 March 2017

Communication and Integration Strategy

Cancer prevention and control in the context of an integrated approach

A framework for malaria elimination

Concept note. 1. Background and rationale

Transcription:

Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030 Dr Walter M Kazadi Coordinator Regional Hub Emergency Response to Artemisinin Resistance Regional Hub GMS MMV 13th stakeholder meeting, Siem Reap 24 26 Feb 2015

Agenda Share the background to the GMS Malaria Elimination Strategy Update on the process and rationale of the strategy development Present an overview of the current draft Strategy Highlight next steps for the finalisation 2

About 120 million people are at risk of malaria in the GMS. It is estimated that in 2012, there were approximately 1.8 million malaria cases (range 1 522 000 2 484 000) of which 58% were due to P. falciparum. *: High risk (> 1 malaria case per 1000 population); Low risk (0 1 malaria case per 1000 pop.) http://alfredmeier.me/2012/02/12/cambodia-vietnamese-investments-in-the-kingdomof-wonder/ accessed 18 June 2014 3

Tremendous progress towards 2015 targets, MOH data, GMS 2014 Cambodia Vietnam Lao PDR Thailand Myanmar China PR 4

Malaria drug resistance, including artemisinin resistance, a genuine threat to gains made in the Region and globally GMS Network: TES and K13 results Tier map September 2014 Tier map February 2015 Strategic information generated through regular TES used to update tier maps and guide prioritisation and resource allocation in the GMS 5

GMS Malaria elimination strategy development the process and rationale A report looking at the feasibility of falciparum malaria elimination in the Greater Mekong Subregion (GMS) was presented to the MPAC in September 2014. The MPAC recommended the adoption of a P. falciparum elimination goal in the GMS by 2030. In parallel, the Heads of States at the 9th East Asian Summit in Myanmar in November 2014, agreed to the goal of an Asia Pacific free of malaria by 2030. In the declaration, the co-chairs of the Asia Pacific Leaders Malaria Alliance (APLMA) were tasked with development of a plan (roadmap) for achieving this goal Since then, a GMS malaria elimination strategy has been drafted under the leadership of the WHO Emergency Response to Artemisinin Resistance (ERAR) Regional Hub The current draft strategy has been revised based on feedback from countries and partners at regional meetings and at in-country consultations and shared with the MPAC for their technical inputs and advice. 6

GMS Malaria elimination strategy Vision, Goal and objectives VISION: The Greater Mekong Sub-Region is free from malaria GOALS: By 2030, to eliminate the disease within affected countries and areas of the GMS, in a sustainable way, within all countries of the GMS. To maintain malaria free status and prevent reintroduction due to importation of malaria in areas where the disease has been eliminated To tackle problems associated with imported malaria. 7

GMS Malaria elimination strategy Vision, Goal and objectives OBJECTIVES: To interrupt transmission of Plasmodium falciparum in areas of malaria drug resistance, including artemisinin resistance, and prevent its spread regionally and globally. To achieve maximum burden reduction in GMS countries and territories where elimination does not appear to be feasible at present. To ultimately interrupt transmission of all forms of malaria in GMS countries and territories where there is clear evidence of political support, technical feasibility, operational and financial applicability of malaria elimination To prevent the re-emergence of malaria transmission due to importation in countries and territories where it had been eliminated. 8

GMS Malaria elimination strategy- Milestones and targets By end of 2015: o All GMS countries have updated their malaria policies and included them into the broader national health policies and planning framework o All GMS countries have revised/updated/developed their National Strategies and Action Plans for malaria elimination, based on GMS Regional Strategy By 2020: o o o By 2025: o o o By 2030: o o Pf malaria eliminated in Cambodia. Malaria eliminated in Yunnan, China. Re-establishment of malaria prevented in countries that are malaria-free Pf malaria eliminated in all GMS countries. Malaria eliminated in Thailand and Cambodia. Re-establishment of malaria prevented in countries that are malaria-free Malaria eliminated in all GMS countries. Re-establishment of malaria prevented in countries that are malaria-free 9

GMS Malaria elimination strategy- Priorities and interventions The GMS malaria elimination strategy refers to the Global Malaria Technical Strategy 2016-2030 and operationalizes it for the GMS, taking into account GMS specificities. The draft elimination strategy describes the current malaria situation and interventions in the GMS, and defines a strategy for malaria elimination in the subregion. The rationale is the worsening multi-drug resistance situation in the GMS, which poses a threat to regional and global health security, and which necessitates urgent action. While the strategy stresses that P. falciparum should be a priority it also notes that planned interventions against falciparum malaria will have considerable impact on vivax malaria transmission as well, because in most endemic areas both species are found and the same vector control strategies are applied. 10

GMS Malaria elimination strategy- Priorities and interventions At regional level, the draft strategy proposes the following priorities: Interrupting transmission in areas with multidrug resistance in the border areas between Cambodia and Thailand; Reducing transmission in the high transmission areas in Myanmar; Controlling malaria in areas of resurgence. At country level, the draft strategy proposes the following priorities: Eliminating in areas of multidrug resistance; Flattening the epidemiological landscape by reducing transmission in areas of high transmission; Local analysis may identify additional priorities such as measures targeting certain mobile populations. The prioritization does not mean that efforts to eliminate malaria in low transmission areas should be put on hold 11

Strategy implementation To succeed, the new GMS strategy has to be translated into effective national elimination programmes and plans of action, where: Notification on each case of malaria is mandatory Adequate case-based malaria surveillance established and fully functional across the entire territory The planning of elimination measures based on epidemiological investigation and classification of each malaria case and focus Universal coverage of disease management achieved A strict total coverage of all active foci by effective vector control measures National malaria elimination database established and operational National monitoring elimination committee set up 12

Strategy implementation Area Objectives Approaches Disease management To detect early and treat radically all infections including asymptomatic, to prevent onward transmission To deplete the remaining reservoir of malaria infection Surveillance To discover any evidence of the continuation or resumption of transmission To detect and notify on all local and imported cases as early as possible To investigate and classify each case and focus of malaria To provide a rapid and adequate response To monitor progress towards malaria elimination Vector control To reduce onward transmission from existing cases To halt local transmission nationwide as soon as possible Monitoring & Evaluation To measure progress made towards interrupting malaria transmission 13 Test, Treat and Track both at HF and Community levels Largely, universal coverage of disease management has been achieved Pf: ACTs and single dose PQ is mandatory Pv: CQ or ACT and PQ is mandatory; may require testing for G6PD deficiency ACD to fill gaps in PCD system in order to detect all infections including asymptomatic ones as early as possible, with particular focus on high risk groups All positive cases should be confirmed by microscopy Notification of each malaria case is mandatory Adequate case- and foci-based malaria surveillance established and fully functional across the entire territory of a country it is mandatory that all reported cases are subject to epidemiological investigation, ideally within 1-2 days Private sector must report every case by law Service provision by other sectors, e.g. military, security forces, corporate sector follows national norms and is monitored A strict total coverage of all active foci by effective vector control measures National computerized malaria elimination database established and operational National monitoring elimination committee set up Data source: notification reports, individual case and focus investigations

Enabling factors Additional novel interventions (such as kits for detection of G6PD, repellents, insecticide-treated clothing, TMT etc.) which require operational research are needed for elimination Investing in human resources, strengthening leadership/management as well as defining the administrative policy and legislation are crucial for elimination programme Cross-border collaboration should be promoted and facilitated at the higher levels of governance in line with the East Asia Summit Declaration 14

Governance of malaria elimination One of the conclusions in the feasibility report presented to the MPAC was that national leadership of a regional elimination effort is essential, and depends on national governments working together. Possible model for governance and coordination of malaria elimination in the GMS The feasibility report recommended that a joint inclusive governance platform to monitor and coordinate implementation should be agreed upon by all parties involved. A governance options paper was prepared and presented to countries at the meeting in Thailand in February 2015. A possible model for regional governance and coordination of malaria elimination in the GMS discussed at the meeting is to have WHO/ERAR hub as the technical arm, APLMA as the political arm, and a revised version of the Global Fund s Regional Artemisinin Resistance Initiative (RAI) Regional Steering Committee (RSC) to oversee activities. 15

Cost & Financing Total cost estimate of elimination (2015-2030, $) Malaria funding in GMS by source ($M) Total cost 2015-30 (USD) 4 3.9 billion 7% 3.2 billion 3 9% 27% Private sector 22% Vector control 17% 2 Surveillance 22% Case 26% 1 23% management 24% 23% Supporting activities 0 Best case scenario Hypotheses Faster decline of Pf. High coverage of LLINs only in high transmission areas & 40% of others Gradual cost-sharing for CHWs Worst case scenario Hypotheses Relatively difficult to reduce Pf malaria Need for high coverage with LLINs in high & low transmission areas 250 200 150 100 50 0 Forecast 2008 2009 2010 2011 2012 2013 2014 2015 2016 GF allocations / disbursements BMGF Government funding WHO (exc China) UNICEF (exc China) Bilaterals (exc China) PMI (exc China) Others 16

The GMS Malaria Elimination Strategy Finalisation and Roll-out 2014 2015 Dec Jan Feb Mar Apr May Jun Phase 1 Phase 1 Country feedback on 2nd draft Phase 2 Phase 3 Phase 2 Further feed-back and peer review of the strategy Phase 3 Update national malaria strategic plans & action plans in line with last draft of the Strategy Key meetings Deliverables Partners' MPAC forum Open web consultation In country strategy consultations 2nd draft 3rd draft 4th draft TODAY 5th draft WHA -Launch the GMS malaria Elimination strategy Country planning workshops Final Strategy Document Updated national action plans Country Action Participate in 1 st GMS consultation (Nov. 2014) Organize in-country consultations and provide feedback on 2nd draft Discuss cross-border & regional components Engage in Partners Forum Provide feedback during open web consultation Conduct in-country planning workshops to update national malaria strategic and action plans Conduct gap analysis Define financial and technical support needs Brief minister of health for WHA 17

Acknowledgments 18